The role of SOX transcription factors and the effect of their dysregulation on cancer progression and on therapy response is not fully understood and some data investigating the impact of SOX2 and SOX9 in OSCC remain controversial.4, 5, 30, 33, 37. The gene discussed is SOX2; the disease is cancer.